Equities

Avricore Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AVCR:CVE

Avricore Health Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.075
  • Today's Change0.00 / 0.00%
  • Shares traded308.00
  • 1 Year change+36.36%
  • Beta0.1938
Data delayed at least 15 minutes, as of Feb 11 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The Company offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.

  • Revenue in CAD (TTM)1.92m
  • Net income in CAD-1.63m
  • Incorporated2000
  • Employees--
  • Location
    Avricore Health Inc1120 - 789 West Pender StreetVANCOUVER V6C 1H2CanadaCAN
  • Phone+1 (604) 773-8943
  • Fax+1 (604) 687-2038
  • Websitehttps://avricore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alphinat Inc1.48m104.23k3.91m------27.522.640.00170.00170.0235-0.00462.06--4.94--14.4715.22----28.5824.917.036.42--2.80----28.820.9771131.88-1.232.02--
Oculus Inc0.00-467.89k4.12m0.00---------0.0051-0.00510.00-0.010.00-------1,640.05-190.02---271.69--------------------44.63------
Visionstate Corp433.08k-1.08m5.17m7.00------11.93-0.0044-0.00440.0018-0.00120.8515--32.77---212.56-137.88-6,108.19-997.8944.09---249.64-249.26---40.00-----12.0427.18-15.48------
Ginsms Inc1.52m-738.77k5.61m--------3.70-0.0039-0.00390.0081-0.01561.46--2.16---71.042.79----37.1439.85-48.770.9612---4.14-----21.40-1.03117.09---22.17--
Destiny Media Technologies Inc6.19m-916.71k6.67m30.00--2.0128.781.08-0.0951-0.09510.64240.34921.38--5.63206,365.60-20.391.85-23.802.1884.3386.48-14.811.61----0.000.002.353.42-670.76--39.23--
Avricore Health Inc1.92m-1.63m7.60m----5.87--3.95-0.0172-0.01720.01970.01280.8828538.956.59---74.80-55.83-86.10-81.6943.4835.20-84.73-49.7417.81--0.00--37.32170.574.60------
Adcore Inc31.75m-529.00k8.84m54.00--0.84458.500.2785-0.0087-0.00870.52420.17191.75--5.73588,029.40-2.91-4.72-4.70-7.1040.4038.66-1.67-3.00----0.0644--2.4615.9742.69--8.46--
Agereh Technologies Inc42.36k-1.01m10.29m--------242.90-0.0109-0.01090.0004-0.06730.1262--3.08---301.00-----------2,385.55--0.1452-1.51--------73.18------
Data as of Feb 11 2026. Currency figures normalised to Avricore Health Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.